GAITHERSBURG, Md., July 02, 2024. artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell...
Vous n'êtes pas connecté
CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the multiple ascending dose (MAD) Part 2 of its...
GAITHERSBURG, Md., July 02, 2024. artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell...
Cartesian Therapeutics, Inc, a clinical─stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first...
Competitive: Syneos Health - USA: Research Nurse Illingworth Research Group provides a range of patient focused clinical services to the...
Competitive: Syneos Health - USA: Research Nurse Illingworth Research Group provides a range of patient focused clinical services to the...
Beam Therapeutics (BEAM) doses the first patient in a phase I/II study, evaluating in vivo base editor BEAM-302 for treating alpha-1 antitrypsin...
Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide, a leading global contract research organization (CRO), works in partnership...
In recent years, the blend of artificial intelligence and healthcare has led to exciting advancements in cancer care. At the core of this change is...
Ava Bolton's family hope the new vaccination treatment will reduce the risk of her neuroblastoma returning.
KalVista initiates KONFIDENT-KID trial for on-demand treatment of hereditary angioedema attacks with sebetralstat in children aged 2 to 11 KalVista...
July 5, 2024 — A group of researchers from the Rady Faculty of Health Sciences and Children’s Hospital Research Institute of Manitoba (CHRIM)...